Navigation Links
Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
Date:5/21/2010

BOSTON, May 21 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. today announced presentation of data in a poster titled "Results from a multicenter, open-label Phase 3 study to determine the safety and efficacy of gadobutrol, a macrocyclic 1.0 molar GBCA in patients referred for contrast-enhanced MRI of the central nervous system (CNS)" at the 48th Annual Meeting of the American Society of Neuroradiology (ASNR) in Boston, MA.  The results of this study of this investigational drug met all of its pre-specified primary efficacy objectives.  Gadobutrol is investigational in the United States and is not approved by the U.S. Food and Drug Administration.

This phase 3 study had four primary efficacy objectives.  In results comparing unenhanced CNS MRI versus the combined unenhanced and gadobutrol-enhanced CNS MRI, statistically significant superiority (P<0.0001) of gadobutrol images compared to unenhanced images was shown for all three individual blinded readers as well as the average blinded reader for three of the primary efficacy variables (internal morphology, degree of contrast enhancement and border delineation).  Non-inferiority was the objective for the number of lesions detected in this study and was demonstrated for two of three blinded readers, as well as the average of the blinded readers.(1)

In the study, 14 subjects (4.1%) reported at least one adverse event which the investigators considered related to gadobutrol.  No deaths were reported during the study period, and none of the subjects discontinued from the study due to an AE.  One subject experienced a serious adverse event (SAE), which was not considered by the investigator to be related to the study drug.

"This was a large mu
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... England and BOSTON , May 24, ... discovery and development company, is pleased to announce that it has ... to augment the Company,s business development capabilities in Japan ... more than 15 years of experience in business development, licensing and ... Sciences, Inc., Roche Pharma ( Japan ), Nippon Roche ...
(Date:5/23/2013)... Calif. , May 23, 2013 Amgen (NASDAQ: ... 38 th Annual  Healthcare Conference on Thursday, May 30, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... at Amgen, will present at the conference. Live audio of ... Amgen,s website, www.amgen.com , under Investors. A replay of ...
(Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... Mylan Inc. (Nasdaq: MYL ) today ... Laboratories Limited) has received final approval from the U.S. ... Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg, ... is the generic version of Pfizer,s Lipitor® Tablets, which ...
... May 29, 2012 Ranbaxy Laboratories Inc. (RLI), a ... announced today that the U.S. Food and Drug Administration ... of the acne medication isotretinoin, for the treatment of ... the Canadian firm, Cipher Pharmaceuticals Inc., RLI is expected ...
Cached Medicine Technology:Mylan Launches Generic Version of Lipitor® 2Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2
(Date:5/25/2013)... 25, 2013 Imagine running the air conditioner ... loss, hot air and wasted energy! If the home has ... fireplace or clothes dryer, that may be just what is ... often overlooked holes waste energy in the form of higher ... cooling loss in the home. , Drafts occur through the ...
(Date:5/25/2013)... Dr. Leslie Gerstman announced today that Ultherapy ... the neck, on the brow and under the chin -- ... is a non-surgical procedure for the face and neck that ... skin over time. The use of FDA-cleared ultrasound technology enables ... the deepest support layers of the skin – typically addressed ...
(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...
(Date:5/25/2013)... Many viruses and parasites that affect both dogs and ... illness than can result in liver or kidney failure ... a veterinarian. These germs could be found ... Dr. Susan Nelson, a clinical associate professor at Kansas ... diseases can be fatal, even with treatment," she said ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Radius ... underground shelter company in the US and has ... structures for over 35 years. M.E. and President, ... Handbook of NBC Weapon Fundamentals and Shelter Engineering ... States’ bible on shelter engineering. McCarthy is considered ...
Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3
... MADISON Most cancers are easier to treat if ... screening and prompt treatment. But for immigrants and other ... early detection even if it,s been translated into ... "Medical interventions fail if the intervention does not match ...
... Minn. -- Mayo Clinic investigators, with Belgian collaborators, have ... effectively heal, repair and regenerate damaged heart tissue. The ... -- appear in today,s Journal of the American ... from patients have normally a limited capacity to repair ...
... News) -- The massive BP oil spill in the Gulf ... fishermen and members of coastal communities, according to a group ... be aware of, and look for, evidence of toxicity from ... asked about occupation and location of residence, the physical examination ...
... associated with cancer progression when abundant inside of tumors ... that feed the tumor outside, a research team led ... Cancer Center reports in the August edition of ... to block production of the protein, the researchers inhibited ...
... of potential health risks posed by secondhand tobacco smoke, ... of using ozone to remove the smell of tobacco ... interiors of vehicles, is probably a bad idea. ... Berkeley National Laboratory (Berkeley Lab) shows that ozone can ...
... Gothenburg, Sweden, have for the first time identified 12 ... The discovery could result in more reliable prognoses and ... in the journal Clinical Cancer Research , are ... breast cancer patients. Half of these patients died within ...
Cached Medicine News:Health News:Building a bridge with cross-cultural cancer education 2Health News:Building a bridge with cross-cultural cancer education 3Health News:Mayo's 'smart' adult stem cells repair hearts 2Health News:Gulf Oil Spill Still a Health Threat to Many, Researchers Report 2Health News:Gulf Oil Spill Still a Health Threat to Many, Researchers Report 3Health News:Novel role: EZH2 boosts creation of ovarian cancer blood vessels 2Health News:Novel role: EZH2 boosts creation of ovarian cancer blood vessels 3Health News:Berkeley study shows ozone and nicotine a bad combination for asthma 2Health News:Berkeley study shows ozone and nicotine a bad combination for asthma 3Health News:Genes associated with aggressive breast cancer 2
... Conforming to U.S. and international engineering ... TC-100 Screw and Plating System* provides ... ease of use for open reduction ... the TC-100 system works well beyond ...
... The CARDIA PFO Occluder ... transvenous closure of Patent Foramen ... sheaths (10-12F) the device offers ... for the percutaneous closure of ...
Half pin skeletal traction pins with cove point....
Round Bevel-Point Pin Sets available in 2.3mm, 3.1mm, 4.7mm, and 6.3mm sizes....
Medicine Products: